LABS
NEUTRALLife Science REIT PLC Announces Holding(s) in Company
The real estate investment trust has received a notification of a change in major shareholding.
Life Science REIT
42.90GBX
-0.23%
Market Cap
150.85M
Volume
60.86k
7% of avg
P/E Ratio
EPS (TTM)
N/A
Beta
N/A
Day Range
0.00p - 0.00p
52 Week Range
0.00p42.90p47.10p
42.90p
Upcoming Events
LABS
NEUTRALLife Science REIT Provides Notice of Annual General Meeting
The real estate investment trust has announced the details of its upcoming annual general meeting, including the date, time, and location.
LABS
NEUTRALLife Science REIT PLC Announces Holding(s) in Company
The real estate investment trust has received a notification of a change in major shareholding.
LABS
BADLife Science REIT Announces Strategic Review Amid Challenging Market Conditions
This real estate investment trust faces significant challenges, including suspended dividends and material uncertainty about its future operations, despite some improvements in occupancy and revenue.
LABS
VERY GOODLife Science REIT Secures New Lease at Oxford Technology Park, Setting Rental Record
The real estate investment trust has signed a new 10-year lease agreement for 5,600 sq. ft. of space at the Oxford Technology Park, setting a new rental record for the park.
LABS
NEUTRALLife Science REIT Announces Regulatory Disclosure
The healthcare REIT has announced a regulatory disclosure regarding a change in major shareholding.
LABS
NEUTRALLife Science REIT Announces Regulatory Threshold Change
The healthcare REIT has announced a change in regulatory shareholding thresholds, with BlackRock's stake falling below 5%.
LABS
GOODLife Science REIT Amends Investment Advisory Agreement, Saving £1M Annually
The property investment firm has revised its investment advisory agreement, resulting in an annual saving of £1 million. This should boost the company's profitability.
LABS
NEUTRALLife Science REIT Announces Director Dealings
The real estate investment trust has disclosed changes to its major shareholders.
LABS
BADLife Science REIT Launches Strategic Review, Suspends Dividends
The property business focused on the UK's life science sector has launched a strategic review, including a formal sale process, after facing challenges since its IPO that have impacted its share price and financial performance.